ArticleEndocrinology, diabetes & metabolism case reports2026

PPAR-α activator pemafibrate lowered plasma insulin-like growth factor-1 level in a patient with acromegaly.

Go YoshimichiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.